YM 43611

Drug Profile

YM 43611

Latest Information Update: 10 Feb 1999

Price : $50

At a glance

  • Originator Yamanouchi
  • Class Antipsychotics; Benzamides
  • Mechanism of Action Dopamine D3 receptor antagonists; Dopamine D4 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Psychotic disorders

Most Recent Events

  • 10 Feb 1999 Discontinued-Preclinical for Psychotic disorders in Japan (Unknown route)
  • 12 Oct 1998 Profile reviewed
  • 26 Oct 1995 Preclinical development for Psychotic disorders in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top